ChromaDex Corporation Reports First Quarter 2022 Financial Results

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #earnings–ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2022. First Quarter 2022 and Recent Highlights Total net sales were $17.3 million, up 18% from the prior year quarter. Tru Niagen® net sales were $14.9 million, a 20% increase from the prior year…